NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zipper therapy breakthrough: new combo may boost recovery in rare brain disease
Disease control Recruiting nowThis study tests a new treatment called Modified Zipper Therapy for people with a rare disease called NMOSD. It combines standard treatments with a drug called eculizumab to help patients recover better from sudden attacks. About 198 adults will take part to see if this approach …
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Phase: PHASE3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New study tracks pregnancy in women with neuroimmune diseases
Knowledge-focused Recruiting nowThis study follows 100 women with neuroimmune diseases (like multiple sclerosis or myasthenia gravis) through pregnancy and up to five years after. Researchers will track disease activity, pregnancy complications, and baby health to learn how these conditions affect fertility and…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC